SWETCHA LANKAPALLI: Open Payments
NPI 1184129975 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,975 in 73 payments from 21 companies in 2025. Trend: 2023 $1,448 · 2024 $1,887 · 2025 $1,975
Food & beverage: $1,803Education: $172
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $463 |
| ABBVIE INC. | 10 | $355 |
| Galderma Laboratories, L.P. | 7 | $200 |
| GENZYME CORPORATION | 7 | $148 |
| UCB, Inc. | 4 | $119 |
| PFIZER INC. | 5 | $113 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| Organon LLC | 4 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| LEO Pharma Inc. | 2 | $58 |
Products named: TREMFYA, RINVOQ, DUPIXENT, NEMLUVIO, Bimzelx, CIBINQO, SKYRIZI, ADBRY.
Industry payments across MD — which companies pay providers there.
